Capricor Therapeutics, Inc. (CAPR)
27.18
-1.49
(-5.20%)
USD |
NASDAQ |
Dec 11, 16:00
27.39
+0.21
(+0.77%)
After-Hours: 20:00
Capricor Therapeutics Free Cash Flow: -68.37M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals, Inc. | 136.04M |
| Inovio Pharmaceuticals, Inc. | -89.08M |
| Perspective Therapeutics, Inc. | -106.85M |
| Arcturus Therapeutics Holdings, Inc. | -61.54M |
| Myomo, Inc. | -13.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.69M |
| Cash from Investing (Quarterly) | 15.95M |
| Cash from Financing (Quarterly) | 0.007M |
| Free Cash Flow Per Share (Quarterly) | -0.5184 |
| Free Cash Flow to Equity (Quarterly) | -37.20M |
| Free Cash Flow to Firm (Quarterly) | -23.70M |
| Free Cash Flow Yield | -5.54% |